Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era
Authors:
- A PhillipsAPA Phillips
- Patrizio PezzottiPPPatrizio Pezzotti
- CASCADE CollaborationCCCASCADE Collaboration
- 1 January 2004
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (1) , 51-58
Abstract
One key piece of information required when deciding whether to initiate antiretroviral therapy is the risk of AIDS before the next clinic visit. Information on the short-term (6-month) risk of AIDS according to the current viral load and CD4 cell count in untreated individuals and those treated in the zidovudine monotherapy era (i.e., pre-September 1995), especially in those with CD4 cell count > 200 × 106 cells/l, is lacking. Risk of AIDS was assessed in 3226 subjects with viral load and CD4 cell count known before initiation of antiretroviral therapy or during the zidovudine monotherapy era. These were from CASCADE Collaboration in which data from 20 cohorts of individuals with known dates of seroconversion to HIV, based in clinics in Europe and Australia, have been combined. During a total 5126.0 person-years of follow-up, 219 individuals developed AIDS. In those with current CD4 cell count < 200 × 106 cells/l, 6-month risks were 4.9, 12.7, 17.7 and 22.4% for viral load groups < 10 000, 10 000–29 999, 30 000– 99 999 and ≥ 100 000 copies/ml, respectively. For CD4 cell counts 200–349 × 106 cells/l risks were 0.5, 1.6, 3.2 and 4.7%, respectively, for the four viral load groups while the corresponding values for group with CD4 cell count ≥ 350 × 106 cells/l were 0.2%, 0.5%, 0.9% and 2.2%, respectively. Results were similar when analysis was restricted to those with no antiretroviral drug experience. Older people had a higher risk of AIDS for a given CD4 cell count and viral load than younger people. Combined with consideration of other issues, these estimates should prove useful information when deciding whether to initiate antiretroviral therapy in HIV-infected individuals.Keywords
This publication has 10 references indexed in Scilit:
- The Relationships between Ethnicity, Sex, Risk Group, and Virus Load in Human Immunodeficiency Virus Type 1 Antiretroviral‐Naive PatientsThe Journal of Infectious Diseases, 2001
- Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADEHIV Medicine, 2000
- Antiretroviral Therapy in AdultsJAMA, 2000
- Plasma HIV Viral Load in Patients with Hemophilia and Late-Stage HIV Disease: A Measure of Current Immune SuppressionAnnals of Internal Medicine, 1999
- Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupInternational Journal of Epidemiology, 1998
- The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infectionAIDS, 1998
- AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and functionAIDS, 1997
- Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual menAIDS, 1997
- Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300×106/lAIDS, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996